FDA Compliance for Peptide Therapy and BPC 157 Holt Law FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times